Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less.

MLA

Reardon, Michael J., et al. “Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less.” JAMA Cardiology, vol. 1, no. 8, Nov. 2016, pp. 945–49. EBSCOhost, https://doi.org/10.1001/jamacardio.2016.2257.

APA

Reardon, M. J., Kleiman, N. S., Adams, D. H., Yakubov, S. J., Coselli, J. S., Deeb, G. M., O’Hair, D., Gleason, T. G., Lee, J. S., Hermiller, J. B., Jr, Chetcuti, S., Heiser, J., Merhi, W., Zorn, G. L., 3rd, Tadros, P., Robinson, N., Petrossian, G., Hughes, G. C., Harrison, J. K., … Popma, J. J. (2016). Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less. JAMA Cardiology, 1(8), 945–949. https://doi.org/10.1001/jamacardio.2016.2257

Chicago

Reardon, Michael J, Neal S Kleiman, David H Adams, Steven J Yakubov, Joseph S Coselli, G Michael Deeb, Daniel O’Hair, et al. 2016. “Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less.” JAMA Cardiology 1 (8): 945–49. doi:10.1001/jamacardio.2016.2257.